InsiderClue
Stocks · Health care · Pharmaceutical Preparations

CDT Equity Inc.

CDT Clue Score3
United States Fiscal year ends December CIK 0001896212
$0.72 -10.25% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.72 −67.06% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 25 Sep 2023. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2022Operating income−3.2Net income−4.9EPS, diluted−0.13Fiscal year 2023Operating income−5.3Net income−0.5EPS, diluted−8.92Fiscal year 2024Operating income−15.4Net income−17.8EPS, diluted−61,598.62Fiscal year 2025Operating income−36.8Net income−39.2EPS, diluted−1,177.89
FY2022FY2023FY2024FY2025
Operating income −3.2 −5.3 −15.4 −36.8
Net income −4.9 −0.5 −17.8 −39.2
Growth
EPS, diluted −0.13 −8.92 −61,598.62 −1,177.89

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2022Operating cash flow−2.3Fiscal year 2023Operating cash flow−7.7Fiscal year 2024Operating cash flow−9.7Capital expenditure−0.1Free cash flow−9.7Fiscal year 2025Operating cash flow−15.6Buybacks−0.1
FY2022FY2023FY2024FY2025
Operating cash flow −2.3 −7.7 −9.7 −15.6
Capital expenditure n/a n/a −0.1 n/a
Free cash flow n/a n/a −9.7 n/a
Growth
Buybacks n/a n/a n/a −0.1

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2022Cash0.3Shareholders’ equity−10.1Fiscal year 2023Cash4.2Shareholders’ equity−0.5Fiscal year 2024Cash0.6Shareholders’ equity−6.8Fiscal year 2025Cash1.5Shareholders’ equity−7.2
FY2022FY2023FY2024FY2025
Cash 0.3 4.2 0.6 1.5
Shareholders’ equity −10.1 −0.5 −6.8 −7.2

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Spending
48.5% n/a n/a n/a
Returns
−97,740.0% −7.4% −424.6% −694.2%
Balance and payout
201,880.0% 106.3% 262.0% 226.9%